Alimera Sciences, Inc. logo

Alimera Sciences, Inc.

NASDAQ:ALIM

Overview | Financials
Company Name Alimera Sciences, Inc.
Symbol ALIM
Currency USD
Price 5.56
Market Cap 302,376,152
Dividend Yield 0%
52-week-range 2.606 - 5.65
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Richard S. Eiswirth Jr.
Website https://alimerasciences.com

An error occurred while fetching data.

About Alimera Sciences, Inc.

Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to

Related Stocks

STRATA Skin Sciences, Inc. logo

STRATA Skin Sciences, Inc.

SSKN

3.259 USD

Eargo, Inc. logo

Eargo, Inc.

EAR

2.57 USD

Greenbrook TMS Inc. logo

Greenbrook TMS Inc.

GBNH

0.121 USD

Eledon Pharmaceuticals, Inc. logo

Eledon Pharmaceuticals, Inc.

ELDN

2.54 USD

Financials

Numbers are in millions USD

Numbers are in millions USD